Literature DB >> 8741082

Prednisone can protect against exercise-induced muscle damage.

S C Jacobs1, A L Bootsma, P W Willems, P R Bär, J H Wokke.   

Abstract

In an experimental animal exercise model we tested whether daily administration of prednisone prevents the development of mechanically induced muscle fibre damage. Six-week-old rats were treated with different doses of prednisone ranging from 1 to 50 mg/kg body weight per day or with placebo, for 8 days. On day 6 of treatment the rats were forced to run for 2 h on a level treadmill. Two days after exercise morphological damage in the soleus muscles was quantified using light microscopy and a semi-automatic image analysis system. Creatine kinase (CK) activity was measured before exercise (day 5) and directly after exercise (day 6). The expression of dystrophin in a placebo group and in a group that received 5 mg prednisone/kg body weight per day with and without performing exercise was studied with Western blotting. The effect of prednisone on fibre type distribution was determined with an antibody against fast myosin and the effect of prednisone on the proliferative activity of muscle satellite cells was studied using bromodeoxyuridine (BrdU) immunohistochemistry. Exercise-induced muscle fibre damage varied in a dose-dependent way. In the placebo group the mean (SEM) damaged muscle fibre area was 4% (1%). The groups that received low doses of prednisone, 1 or 2.5 mg/kg per day, showed a similar level of muscle damage. However, with 5 mg prednisone/kg per day the amount of muscle fibre damage [mean (SEM)] was significantly reduced to 1.4% (0.5%) (P <or= 0.05, Student's t-test). High doses of prednisone had no protective effect. Directly after exercise the CK activity was increased two-fold, except in the group that received 50 mg prednisone/kg body weight per day. No changes in the amount of dystrophin were found after densitometric analysis of the Western blots. Prednisone did not affect the fibre distribution or the labelling index of satellite cells. We conclude that prednisone, given in an appropriate dose, protects muscle fibres against the development of mechanically induced damage, possibly by stabilizing the muscle fibre membranes. This action may explain the beneficial effect of prednisone observed in Duchenne muscular dystrophy patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741082     DOI: 10.1007/bf00869001

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Heavy metal intensification of DAB-based HRP reaction product.

Authors:  J C Adams
Journal:  J Histochem Cytochem       Date:  1981-06       Impact factor: 2.479

2.  Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro.

Authors:  R M Sklar; R H Brown
Journal:  J Neurol Sci       Date:  1991-01       Impact factor: 3.181

3.  Exercise-induced muscle protein leakage in the rat. Effects of hormonal manipulation.

Authors:  G J Amelink; P R Bär
Journal:  J Neurol Sci       Date:  1986-11       Impact factor: 3.181

4.  Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma.

Authors:  K Ohlendieck; K Matsumura; V V Ionasescu; J A Towbin; E P Bosch; S L Weinstein; S W Sernett; K P Campbell
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

5.  A morphological/biochemical study on the actions of corticosteroids on rat skeletal muscle.

Authors:  F J Kelly; J A McGrath; D F Goldspink; M J Cullen
Journal:  Muscle Nerve       Date:  1986-01       Impact factor: 3.217

6.  Methylprednisolone selectively affects dystrophin expression in human muscle cultures.

Authors:  O Hardiman; R M Sklar; R H Brown
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

7.  Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.

Authors:  J T Kissel; D J Lynn; K W Rammohan; J P Klein; R C Griggs; R T Moxley; V A Cwik; M H Brooke; J R Mendell
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

8.  Satellite cell activation after muscle damage in young and adult rats.

Authors:  S C Jacobs; J H Wokke; P R Bär; A L Bootsma
Journal:  Anat Rec       Date:  1995-07

9.  Exercise-induced necrotic muscle damage and enzyme release in the four days following prolonged submaximal running in rats.

Authors:  J Komulainen; V Vihko
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

10.  Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.

Authors:  F F Davidson; E A Dennis; M Powell; J R Glenney
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

View more
  20 in total

1.  Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy.

Authors:  Ida Luisa Rotundo; Stefania Faraso; Elvira De Leonibus; Gerardo Nigro; Carmen Vitiello; Alessio Lancioni; Daniele Di Napoli; Sigismondo Castaldo; Vincenzo Russo; Fabio Russo; Giulio Piluso; Alberto Auricchio; Vincenzo Nigro
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

2.  Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.

Authors:  Luca Bello; Heather Gordish-Dressman; Lauren P Morgenroth; Erik K Henricson; Tina Duong; Eric P Hoffman; Avital Cnaan; Craig M McDonald
Journal:  Neurology       Date:  2015-08-26       Impact factor: 9.910

3.  Does post-exercise massage treatment reduce delayed onset muscle soreness? A systematic review.

Authors:  E Ernst
Journal:  Br J Sports Med       Date:  1998-09       Impact factor: 13.800

4.  Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

Authors:  Kevin M Flanigan; Katie Campbell; Laurence Viollet; Wei Wang; Ana Maria Gomez; Christopher M Walker; Jerry R Mendell
Journal:  Hum Gene Ther       Date:  2013-09       Impact factor: 5.695

5.  To Compare the Effect of Vibration Therapy and Massage in Prevention of Delayed Onset Muscle Soreness (DOMS).

Authors:  Shagufta Imtiyaz; Zubia Veqar; M Y Shareef
Journal:  J Clin Diagn Res       Date:  2014-01-12

6.  Hydroxyl radical formation in skeletal muscle of rats with glucocorticoid-induced myopathy.

Authors:  Shingo Konno
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

7.  Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation.

Authors:  Shamik Sen; Manorama Tewari; Allison Zajac; Elisabeth Barton; H Lee Sweeney; Dennis E Discher
Journal:  Eur J Cell Biol       Date:  2011 Feb-Mar       Impact factor: 4.492

8.  Effects of prednisolone on skeletal muscle contractility in mdx mice.

Authors:  Kristen A Baltgalvis; Jarrod A Call; Jason B Nikas; Dawn A Lowe
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

9.  Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans.

Authors:  Anna Rufo; Andrea Del Fattore; Mattia Capulli; Francesco Carvello; Loredana De Pasquale; Serge Ferrari; Dominique Pierroz; Lucia Morandi; Michele De Simone; Nadia Rucci; Enrico Bertini; Maria Luisa Bianchi; Fabrizio De Benedetti; Anna Teti
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

10.  Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice.

Authors:  Erin R Wissing; Douglas P Millay; Grégoire Vuagniaux; Jeffery D Molkentin
Journal:  Neuromuscul Disord       Date:  2010-07-15       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.